TY - JOUR
T1 - Innate Immune Signaling Contributes to Tubular Cell Senescence in the Glis2 Knockout Mouse Model of Nephronophthisis
AU - Jin, Heng
AU - Zhang, Yan
AU - Liu, Dingxiao
AU - Wang, Shan Shanshan
AU - Ding, Qiong
AU - Rastogi, Prerna
AU - Purvis, Madison
AU - Wang, Angela
AU - Elhadi, Sarah
AU - Ren, Chongyu
AU - Cao, Chao
AU - Chai, Yanfen
AU - Igarashi, Peter
AU - Jetten, Anton M.
AU - Lu, Dongmei
AU - Attanasio, Massimo
N1 - Funding Information:
Supported by NIH grants 1R01DK090326 (M.A.) and Z01-ES-101585 (A.M.J.); the National Natural Science Foundation of China grant 81871593 (Y.C.); the National Institute of Environmental Health Sciences Intramural Research Program; and the Fundamental Research Funds for the Central Universities, China, grant 3332019127 (H.J.).
Publisher Copyright:
© 2020 American Society for Investigative Pathology
PY - 2020/1
Y1 - 2020/1
N2 - Nephronophthisis (NPHP), the leading genetic cause of end-stage renal failure in children and young adults, is a group of autosomal recessive diseases characterized by kidney-cyst degeneration and fibrosis for which no therapy is currently available. To date, mutations in >25 genes have been identified as causes of this disease that, in several cases, result in chronic DNA damage in kidney tubular cells. Among such mutations, those in the transcription factor–encoding GLIS2 cause NPHP type 7. Loss of function of mouse Glis2 causes senescence of kidney tubular cells. Senescent cells secrete proinflammatory molecules that induce progressive organ damage through several pathways, among which NF-κB signaling is prevalent. Herein, we show that the NF-κB signaling is active in Glis2 knockout kidney epithelial cells and that genetic inactivation of the toll-like receptor (TLR)/IL-1 receptor or pharmacologic elimination of senescent cells (senolytic therapy) reduces tubule damage, fibrosis, and apoptosis in the Glis2 mouse model of NPHP. Notably, in Glis2, Tlr2 double knockouts, senescence was also reduced and proliferation was increased, suggesting that loss of TLR2 activity improves the regenerative potential of tubular cells in Glis2 knockout kidneys. Our results further suggest that a combination of TLR/IL-1 receptor inhibition and senolytic therapy may delay the progression of kidney disease in NPHP type 7 and other forms of this disease.
AB - Nephronophthisis (NPHP), the leading genetic cause of end-stage renal failure in children and young adults, is a group of autosomal recessive diseases characterized by kidney-cyst degeneration and fibrosis for which no therapy is currently available. To date, mutations in >25 genes have been identified as causes of this disease that, in several cases, result in chronic DNA damage in kidney tubular cells. Among such mutations, those in the transcription factor–encoding GLIS2 cause NPHP type 7. Loss of function of mouse Glis2 causes senescence of kidney tubular cells. Senescent cells secrete proinflammatory molecules that induce progressive organ damage through several pathways, among which NF-κB signaling is prevalent. Herein, we show that the NF-κB signaling is active in Glis2 knockout kidney epithelial cells and that genetic inactivation of the toll-like receptor (TLR)/IL-1 receptor or pharmacologic elimination of senescent cells (senolytic therapy) reduces tubule damage, fibrosis, and apoptosis in the Glis2 mouse model of NPHP. Notably, in Glis2, Tlr2 double knockouts, senescence was also reduced and proliferation was increased, suggesting that loss of TLR2 activity improves the regenerative potential of tubular cells in Glis2 knockout kidneys. Our results further suggest that a combination of TLR/IL-1 receptor inhibition and senolytic therapy may delay the progression of kidney disease in NPHP type 7 and other forms of this disease.
UR - http://www.scopus.com/inward/record.url?scp=85076370324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076370324&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2019.09.013
DO - 10.1016/j.ajpath.2019.09.013
M3 - Article
C2 - 31676329
AN - SCOPUS:85076370324
SN - 0002-9440
VL - 190
SP - 176
EP - 189
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 1
ER -